A Personalized Remote Radiation-Tracking Vest for At-Home Monitoring of LU-177 DOTATATE Therapy

被引:0
|
作者
Pierce, Larry [1 ]
Harrison, Robert [1 ]
Vesselle, Hubert [1 ]
Miyaoka, Robert [1 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:483 / 483
页数:1
相关论文
共 50 条
  • [21] Calibration of an environmental monitoring system for a radiometabolic therapy ward using Lu-177
    Grieco, M.
    Zagni, F.
    Mostacci, D.
    Strigari, L.
    RADIATION EFFECTS AND DEFECTS IN SOLIDS, 2024, 179 (3-4): : 451 - 457
  • [22] RADIATION EXPOSURES FROM LU-177 OCTREOTATE RADIOPEPTIDE THERAPY FOR NEUROENDOCRINE TUMOURS
    Calais, P.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 43 - 43
  • [23] Initial experience of establishing 177Lu DOTATATE therapy and radiation protection
    Meades, R. T.
    Towey, D. J.
    Perry, L.
    Naji, M.
    Zerizer, I.
    Al-Nahhas, A.
    Nijran, K. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S440 - S441
  • [24] Radiation self-monitoring at home of patients receiving 177Lu-DOTATATE peptide receptor radio-therapy for dosimetry informed radiation protection
    Livieratos, L.
    Brothwood, T.
    Aniceto, D.
    Fernandez, R.
    Sibley-Allen, C.
    Adamson, K.
    Allen, S.
    Lewington, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S405 - S405
  • [25] A 10-Year Evolution of Patient Dosimetry for Lu-177 Dotatate Peptide Receptor Radionuclide Therapy (PRRT)
    Ross, Erin
    Ram, Lydia
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [26] Relationship between baseline GFR, [Lu-177]-DOTATATE Clearance and Radiation Dose to Kidneys During Radionuclide Therapy for Somatostatin-Expressing Tumours
    Bailey, D. L.
    Hennessy, T. M.
    Willowson, K. P.
    Chan, D. L.
    Schembri, G. P.
    Aslani, A.
    Pavlakis, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S84 - S84
  • [27] 177Lu-Dotatate effective half-life estimation for personalized radiation protection recommendations
    Sanchez-Perez, M.
    Pena, S.
    Andres, C.
    Villar, C.
    Soto, R.
    Alvarez, N.
    Sebastian, F.
    Ruano, R.
    Torres, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S44 - S45
  • [28] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Yeokyeong Shin
    Bo Hyun Moon
    Baek-Yeol Ryoo
    Heung-Moon Chang
    Kyu-pyo Kim
    Yong Sang Hong
    Tae Won Kim
    Jin-Sook Ryu
    Yong-il Kim
    Changhoon Yoo
    Targeted Oncology, 2024, 19 : 41 - 49
  • [29] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Shin, Yeokyeong
    Moon, Bo Hyun
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Kim, Kyu-pyo
    Hong, Yong Sang
    Kim, Tae Won
    Ryu, Jin-Sook
    Kim, Yong-il
    Yoo, Changhoon
    TARGETED ONCOLOGY, 2024, 19 (01) : 41 - 49
  • [30] Personalized therapy planning for 177Lu-DOTATATE using a kidney-driven dose optimization method
    Mirando, David
    Dewaraja, Yuni
    Kruzer, Alexandria
    Nelson, Aaron
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60